In-vivo Imaging Market 2018 – Major Participants are; FUJIFILM VisualSonics Inc., Mediso Ltd., Biospace Lab S.A., and New England Biolabs

The prevalence of diseases such as cancer involves diagnosis, to know how the cancerous cell are evolving inside the host. This factor is used to provide effective treatment to the cancer patients. This is facilitated by the in vivo imaging techniques. Moreover, in preclinical studies it is often required to test the drug on animal models to know the mechanism of drug binding to its target and vice versa, which has increased the in vivo imaging R&D over the last few years. This facilitates the growth of In-vivo Imaging Market.
According to report published by the National Cancer Institute in 2016, which states that the number of new cancer cases were about 1.6 million in 2016, followed by an increase in the national expenditure for cancer, which was about USD 125 billion in 2010 and is expected to reach USD 156 billion by 2020.
As compared to 2014, an estimated 15,780 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,960 died of the disease. The most common cancers in 2016 were to be breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, thyroid cancer, kidney and renal pelvis cancer, leukaemia, endometrial cancer, and pancreatic cancer.
This will increase the demand for the diagnosis of cancer, which will boost the In Vivo Imaging market. Moreover, increasing prevalence of cancer, rising R&D in imaging, and increasing healthcare expenditures will drive the growth of the global market over the review period. However, lack of awareness among people as well as skilled physician and high cost of the diagnostics method will restrain the In Vivo Imaging market growth during the assessment period.

Worldwide In-vivo Imaging Market - Competitive Analysis
Some of the key players profiled in the report are Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc., Aspect Imaging., TRIFOIL IMAGING, MR Solutions, Biospace Lab S.A., and New England Biolabs.

Try Sample Report Here @ https://www.marketresearchfuture.com/sample_request/780 .

November, 2017 - Aspect Imaging presented its Embrace® Neonatal MRI System at RSNA 2017. As per company reports, it is world’s first FDA-cleared and CE-approved dedicated MRI system installed in the NICU, and was showcased at Radiological Society of North America (RSNA) conference. The company is also announced its partnership with Natus Medical Inc. as its exclusive US distributor for Embrace. Additionally, Natus Medical Inc, is one of the leading provider of healthcare products and services, had collaborated exclusively distribute Embrace® Neonatal MRI system in North America. With this partnership, Embrace will reach more infants in NICUs in the US and Canada and improve neonatal care.
June, 2017 - MILabs B.V. provides high-end molecular imaging solutions for biomedical and pharmaceutical research. MILabs Launched new 5-series pre-clinical imaging platform at SNMMI 2017. As per company reports, this integrated PET-SPECT-OI-CT imaging solution is expected to enable even more significant breakthroughs in anatomical, functional and molecular imaging.

Segments of In Vivo Imaging Market
The global in vivo imaging market has been segmented on the basis of applications, techniques, and end users.
Based on the applications, the market has been segmented into nuclear imaging, optical imaging, and others.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/780 .

Based on the techniques, the market has been segmented as radioisotopes based, biomarkers based, luminescent proteins based technique, and others.
Based on the end users, the market has been segmented as hospitals & clinics, imaging centers, research organizations, and others.
…Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.